Axa’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.79M Sell
516,500
-43,019
-8% -$399K 0.01% 574
2025
Q1
$4.1M Sell
559,519
-78,313
-12% -$574K 0.01% 590
2024
Q4
$5.45M Sell
637,832
-1,015
-0.2% -$8.67K 0.02% 521
2024
Q3
$5.56M Buy
638,847
+182
+0% +$1.58K 0.02% 521
2024
Q2
$4.37M Buy
638,665
+360
+0.1% +$2.46K 0.01% 562
2024
Q1
$5.81M Buy
638,305
+179
+0% +$1.63K 0.02% 521
2023
Q4
$2.85M Sell
638,126
-1,108
-0.2% -$4.94K 0.01% 671
2023
Q3
$2.01M Buy
639,234
+164,334
+35% +$516K 0.01% 710
2023
Q2
$2.45M Buy
+474,900
New +$2.45M 0.01% 680